{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T13:23:42Z","timestamp":1769088222333,"version":"3.49.0"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Hepatic sinusoidal obstruction syndrome (HSOS) is a vascular liver disease with a high mortality rate, and treatment methods are limited. Rivaroxaban is an oral anticoagulant. This study aimed to investigate the pharmacological effect and potential mechanism of rivaroxaban on HSOS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this study, we induced an HSOS mouse model in male C57BL\/6J mice by administering monocrotaline orally. The mice were randomly divided into four groups: the control group, the rivaroxaban (RIV) group, the monocrotaline (MCT) group, and the monocrotaline + rivaroxaban (MCT + RIV) group. Liver function and histopathology were evaluated. 16S rDNA sequencing of the small intestinal contents, transcriptomic sequencing of small intestine tissues, real-time qPCR, Western blot analysis of liver tissues, and correlation analysis were conducted. Antibiotic (ABX) treatment and fecal microbiota transplantation (FMT) experiments were also performed to explore the role of the gut microbiota.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Compared with the MCT group, rivaroxaban alleviated serum biochemical liver function analysis and liver histopathology in the MCT + RIV group. Additionally, 16S rDNA sequencing of the small intestinal contents revealed that, compared with the MCT group, the MCT + RIV group presented increased relative abundances of Allobaculum and Pediococcus but decreased relative abundances of Streptococcus, Staphylococcus, and Candidatus Arthromitus. Mechanistically, integrated analyses, including transcriptomic sequencing of small intestin e tissues, real-time qPCR, Western blot analysis of liver tissues, and correlation analysis, demonstrated that rivaroxaban protected against MCT-HSOS by inhibiting the PI3K\/Akt signaling pathway. In addition, antimicrobial cocktail (ABX) treatment eliminated the beneficial effects of rivaroxaban on liver function and histopathological injury, whereas fecal microbiota transplantation (FMT) from rivaroxaban-treated donors significantly ameliorated liver dysfunction and histological damage in MCT-HSOS mice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>These findings suggest that rivaroxaban alleviates hepatic sinusoidal obstruction syndrome in mice by modulating the gut microbiota and inhibiting the PI3K\/Akt signaling pathway. Rivaroxaban may be a promising therapeutic option for treating HSOS.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmicb.2025.1607131","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T05:27:14Z","timestamp":1755754034000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Rivaroxaban alleviates hepatic sinusoidal obstruction syndrome in mice by modulating the gut microbiota and inhibiting the PI3K\/Akt signaling pathway"],"prefix":"10.3389","volume":"16","author":[{"given":"Wencheng","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanbin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junlin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingyu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quansheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/8886210","article-title":"Rivaroxaban: expanded role in cardiovascular disease management-a literature review","volume":"2021","author":"Ajmal","year":"2021","journal-title":"Cardiovasc. Ther."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J. Hepatol."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism","volume":"363","author":"Bauersachs","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/s41467-017-01186-z","article-title":"Hyperlipidemia-induced cholesterol crystal production by endothelial cells promotes atherogenesis","volume":"8","author":"Baumer","year":"2017","journal-title":"Nat. Commun."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2352-3026(17)30014-5","article-title":"Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial","volume":"4","author":"Beyer-Westendorf","year":"2017","journal-title":"Lancet Haematol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.dld.2018.02.012","article-title":"Actinobacteria: a relevant minority for the maintenance of gut homeostasis","volume":"50","author":"Binda","year":"2018","journal-title":"Dig. Liver Dis."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.3389\/fimmu.2020.00489","article-title":"Diagnosis and treatment of VOD\/SOS after allogeneic hematopoietic stem cell transplantation","volume":"11","author":"Bonifazi","year":"2020","journal-title":"Front. Immunol."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"367","DOI":"10.4161\/gmic.1.6.14390","article-title":"Morphology of segmented filamentous bacteria and their patterns of contact with the follicle-associated epithelium of the mouse terminal ileum: implications for the elationship with the immune system","volume":"1","author":"Caselli","year":"2010","journal-title":"Gut Microbes"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/S0140-6736(20)32439-9","article-title":"Direct oral anticoagulants: evidence and unresolved issues","volume":"396","author":"Chan","year":"2020","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"10839","DOI":"10.18632\/aging.102488","article-title":"HIF-2\u03b1 upregulation mediated by hypoxia promotes NAFLD-HCC progression by activating lipid synthesis via the PI3K-AKT-mTOR pathway","volume":"11","author":"Chen","year":"2019","journal-title":"Aging"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"105101","DOI":"10.1016\/j.bioorg.2021.105101","article-title":"3-Arylamino-quinoxaline-2-carboxamides inhibit the PI3K\/Akt\/mTOR signaling pathways to activate P53 and induce apoptosis","volume":"114","author":"Chen","year":"2021","journal-title":"Bioorg. Chem."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/nature01326","article-title":"The immunopathogenesis of sepsis","volume":"420","author":"Cohen","year":"2002","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.bbmt.2009.08.024","article-title":"Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome","volume":"16","author":"Coppell","year":"2010","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41564-017-0031-4","article-title":"Streptococci target inflammasome","volume":"2","author":"Cunningham","year":"2017","journal-title":"Nat. Microbiol."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1002\/hep.26695","article-title":"Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice","volume":"59","author":"De Minicis","year":"2014","journal-title":"Hepatology"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"G1045","DOI":"10.1152\/ajpgi.00526.2002","article-title":"Embolization by sinusoidal lining cells obstructs the microcirculation in rat sinusoidal obstruction syndrome","volume":"284","author":"DeLeve","year":"2003","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1002\/hep.510290615","article-title":"Characterization of a reproducible rat model of hepatic veno-occlusive disease","volume":"29","author":"DeLeve","year":"1999","journal-title":"Hepatology"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/bjh.12558","article-title":"BCSH\/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation","volume":"163","author":"Dignan","year":"2013","journal-title":"Br. J. Haematol."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.biocel.2015.08.005","article-title":"p27Kip1 signaling: transcriptional and post-translational regulation","volume":"68","author":"Hnit","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fimmu.2022.877650","article-title":"D-mannose regulates hepatocyte lipid metabolism via PI3K\/Akt\/mTOR signaling pathway and ameliorates hepatic steatosis in alcoholic liver disease","volume":"13","author":"Hu","year":"2022","journal-title":"Front. Immunol."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.jacbts.2021.09.010","article-title":"Rivaroxaban, a direct Oral factor xa inhibitor, attenuates atherosclerosis by alleviating factor xa-PAR2-mediated autophagy suppression","volume":"6","author":"Ito","year":"2021","journal-title":"JACC Basic Transl Sci."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.cell.2009.09.033","article-title":"Induction of intestinal Th17 cells by segmented filamentous Bacteria","volume":"139","author":"Ivanov","year":"2009","journal-title":"Cell"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e007230","DOI":"10.1161\/CIRCOUTCOMES.120.007230","article-title":"Bleeding risk of direct Oral anticoagulants in patients with heart failure and atrial fibrillation","volume":"14","author":"Jackevicius","year":"2021","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1002\/cbin.11607","article-title":"Germacrone improves liver fibrosis by regulating the PI3K\/AKT\/mTOR signalling pathway","volume":"45","author":"Ji","year":"2021","journal-title":"Cell Biol. Int."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.4014\/jmb.1505.05002","article-title":"Probiotic mixture KF attenuates age-dependent memory deficit and lipidemia in Fischer 344 rats","volume":"25","author":"Jin-Ju","year":"2015","journal-title":"J. Microbiol. Biotechnol."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e9302","DOI":"10.15252\/emmm.201809302","article-title":"The role of the microbiome in NAFLD and NASH","volume":"11","author":"Kolodziejczyk","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.taap.2016.05.016","article-title":"TCDD modulation of gut microbiome correlated with liver and immune toxicity in streptozotocin (STZ)-induced hyperglycemic mice","volume":"304","author":"Lefever","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fphar.2022.843872","article-title":"Combined use of bicyclol and berberine alleviates mouse nonalcoholic fatty liver disease","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"3860","DOI":"10.1021\/acs.molpharmaceut.8b00347","article-title":"Diammonium glycyrrhizinate protects against nonalcoholic fatty liver disease in mice through modulation of gut microbiota and restoration of intestinal barrier","volume":"15","author":"Li","year":"2018","journal-title":"Mol. Pharm."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1002\/jcp.30807","article-title":"Favorable effect of rivaroxaban against vascular dysfunction in diabetic mice by inhibiting NLRP3 inflammasome activation","volume":"237","author":"Li","year":"2022","journal-title":"J. Cell. Physiol."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.cca.2020.10.025","article-title":"Lipophagy in atherosclerosis","volume":"511","author":"Liu","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"e22287","DOI":"10.1002\/jbt.22287","article-title":"Inhibition of activated factor X; a new pathway in ameliorating carbon tetrachloride\u2013induced liver fibrosis in rats","volume":"33","author":"Mahmoud","year":"2019","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1021\/acs.jafc.8b05943","article-title":"Maltol mitigates thioacetamide-induced liver fibrosis through TGF-\u03b21-mediated activation of PI3K\/Akt signaling pathway","volume":"67","author":"Mi","year":"2019","journal-title":"J. Agric. Food Chem."},{"key":"ref34","first-page":"85","article-title":"Fighting fatty liver diseases with nutritional interventions, probiotics, symbiotics, and fecal microbiota transplantation (FMT)","volume-title":"Probiotics and child gastrointestinal health: Advances in microbiology, infectious diseases and public health","author":"Nobili","year":"2019"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1093\/bioinformatics\/btu494","article-title":"STAMP: statistical analysis of taxonomic and functional profiles","volume":"30","author":"Parks","year":"2014","journal-title":"Bioinformatics"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"101806","DOI":"10.1016\/j.pneurobio.2020.101806","article-title":"Microbiota-gut-brain axis in health and disease: is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications?","volume":"191","author":"Pellegrini","year":"2020","journal-title":"Prog. Neurobiol."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1097\/MEG.0000000000001630","article-title":"Clinical efficacy and safety of anticoagulation therapy for pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: a retrospective multicenter cohort study","volume":"32","author":"Peng","year":"2020","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.freeradbiomed.2016.11.037","article-title":"Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation","volume":"102","author":"Porras","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature13568","article-title":"Alterations of the human gut microbiome in liver cirrhosis","volume":"513","author":"Qin","year":"2014","journal-title":"Nature"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/1462-2920.13463","article-title":"Pediatric obesity is associated with an altered gut microbiota and discordant shifts in Firmicutes populations","volume":"19","author":"Riva","year":"2017","journal-title":"Environ. Microbiol."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.thromres.2010.09.008","article-title":"The mechanism of action of rivaroxaban \u2013 an oral, direct factor xa inhibitor \u2013 compared with other anticoagulants","volume":"127","author":"Samama","year":"2011","journal-title":"Thromb. Res."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1182\/blood.2019000553","article-title":"Overexpression of wild-type IL-7R\u03b1 promotes T-cell acute lymphoblastic leukemia\/lymphoma","volume":"138","author":"Silva","year":"2021","journal-title":"Blood"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"749","DOI":"10.21873\/invivo.11535","article-title":"Protective role of peroxiredoxin I in heat-killed Staphylococcus Aureus-infected mice","volume":"33","author":"Sun","year":"2019","journal-title":"In Vivo"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1053\/j.gastro.2014.10.042","article-title":"Gut-liver axis in alcoholic liver disease","volume":"148","author":"Szabo","year":"2015","journal-title":"Gastroenterology"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1016\/j.jhep.2020.11.013","article-title":"The microbiota in cirrhosis and its role in hepatic decompensation","volume":"75","author":"Trebicka","year":"2021","journal-title":"J. Hepatol."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1002\/hep.29084","article-title":"The anticoagulant rivaroxaban lowers portal hypertension in cirrhotic rats mainly by deactivating hepatic stellate cells","volume":"65","author":"Vilaseca","year":"2017","journal-title":"Hepatology"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41420-019-0198-y","article-title":"Hyperglycemia exacerbates acetaminophen-induced acute liver injury by promoting liver-resident macrophage proinflammatory response via AMPK\/PI3K\/AKT-mediated oxidative stress","volume":"5","author":"Wang","year":"2019","journal-title":"Cell Death Discov."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3389\/fmicb.2019.00165","article-title":"Histopathological features and composition of gut microbiota in Rhesus monkey of alcoholic liver disease","volume":"10","author":"Wang","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.3748\/wjg.v25.i28.3753","article-title":"Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: pathogenesis, clinical manifestations, diagnosis, treatment, and outcomes","volume":"25","author":"Yang","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S1875-5364(20)30018-2","article-title":"Selenium-enriched Bifidobacterium longum protected alcohol and high fat diet induced hepatic injury in mice","volume":"18","author":"Yi","year":"2020","journal-title":"Chin. J. Nat. Med."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.tox.2012.03.005","article-title":"PI3K\/Akt pathway activation was involved in acute ethanol-induced fatty liver in mice","volume":"296","author":"Zeng","year":"2012","journal-title":"Toxicology"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ejphar.2016.12.015","article-title":"Quercetin and baicalein suppress monocrotaline-induced hepatic sinusoidal obstruction syndrome in rats","volume":"795","author":"Zhang","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/s41401-018-0155-y","article-title":"Gynura Rhizoma containing pyrrolizidine alkaloids induces the hepatic sinusoidal obstruction syndrome in mice via upregulating fibrosis-related factors","volume":"40","author":"Zhang","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.etap.2016.07.002","article-title":"Chlorogenic acid suppresses monocrotaline-induced sinusoidal obstruction syndrome: the potential contribution of NF\u03baB, Egr1, Nrf2, MAPKs and PI3K signals","volume":"46","author":"Zheng","year":"2016","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"649060","DOI":"10.3389\/fcimb.2021.649060","article-title":"Streptococcus, the predominant bacterium to predict the severity of liver injury in alcoholic liver disease","volume":"11","author":"Zhong","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/s41401-020-00553-9","article-title":"Tu-San-qi (Gynura japonica): the culprit behind pyrrolizidine alkaloid-induced liver injury in China","volume":"42","author":"Zhu","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/jgh.14612","article-title":"Expert consensus on the clinical management of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome","volume":"34","author":"Zhuge","year":"2019","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1111\/liv.13684","article-title":"Clinical characteristics and treatment of pyrrolizidine alkaloid-related hepatic vein occlusive disease","volume":"38","author":"Zhuge","year":"2018","journal-title":"Liver Int."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2025.1607131\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T05:27:15Z","timestamp":1755754035000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2025.1607131\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":58,"alternative-id":["10.3389\/fmicb.2025.1607131"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2025.1607131","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]},"article-number":"1607131"}}